| (210) | Number of the EPO application | 16774750 |
| (220) | Filing date of the EPO application | 2016.09.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 25/2020, 2020.06.17 |
| (110) | EPO patent number | 3350223 |
| (11) | Number of the document | MD 3350223 T2 |
| (21) | Number of the application | e 2018 0714 |
| (71) | Name(s) of applicant(s), code of the country | Cephalon, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | POULTON Lynn Dorothy, AU;
POLLARD Matthew, AU;
DOYLE Anthony G., AU;
COOKSEY Bridget Ann, AU;
PANDE Vanya, AU;
CLARKE Adam William, AU; |
| (73) | Name(s) of owner(s), code of the country | CEPHALON Inc., US; |
| (54) | Title of the invention | Antibodies that specifically bind to tl1a |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); A61P 37/06 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.09.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2020.09.30 |
| (30) | Priority | 201562220442 P, 2015.09.18, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/052040, 2016.09.16 |
| (87) | International publication | WO 2017/049024, 2017.03.23 |